| Q40394251 | A new strategy for the treatment of inflammatory pain. Prevention or elimination of central sensitization |
| Q47850527 | A possible role for saliva as a diagnostic fluid in patients with chronic pain |
| Q40932806 | A review on the strategies for the development and application of new anti-arthritic agents |
| Q44209140 | A role for endocannabinoids in indomethacin-induced spinal antinociception |
| Q44288444 | A spinal mechanism for the peripheral anti-inflammatory action of indomethacin |
| Q92227580 | Ablation of spinal cord estrogen receptor α-expressing interneurons reduces chemically induced modalities of pain and itch |
| Q28379551 | Absence of prostaglandin E2-induced hyperalgesia in NMDA receptor epsilon subunit knockout mice |
| Q41663135 | Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P |
| Q41780863 | Acetaminophen prevents hyperalgesia in central pain cascade |
| Q35633022 | Activation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cholecystokinin elicits release of prostaglandin-E₂ in the spinal cord |
| Q34809091 | Activation of presynaptic NMDA receptors coupled to NaV1.8-resistant sodium channel C-fibers causes retrograde mechanical nociceptor sensitization |
| Q36449385 | Activation of the neurokinin-1 receptor by substance P triggers the release of substance P from cultured adult rat dorsal root ganglion neurons |
| Q41809903 | Activin acts with nerve growth factor to regulate calcitonin gene-related peptide mRNA in sensory neurons |
| Q34418309 | Acute pain management in children |
| Q33649053 | Acute pain mechanisms |
| Q37150552 | Advanced Genetic Testing Comes to the Pain Clinic to Make a Diagnosis of Paroxysmal Extreme Pain Disorder |
| Q72684125 | Advances in anti-inflammatory therapy |
| Q40646776 | Altered pain perception and inflammatory response in mice lacking prostacyclin receptor |
| Q40735769 | Altered spinal arachidonic acid turnover after peripheral nerve injury regulates regional glutamate concentration and neuropathic pain behaviors in rats |
| Q38167857 | An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets |
| Q40810874 | Analgesic effects of nonsteroidal anti-inflammatory drugs in cancer pain due to somatic or visceral mechanisms. |
| Q34371837 | Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance |
| Q70865314 | Antinociceptive activities of non-steroidal antiinflammatory drugs (NSAIDs) following intracerebroventricular (i.c.v.) and intrathecal (i.t.) administration in mice |
| Q35873011 | Antinociceptive activity of the tachykinin NK1 receptor antagonist, CP-99,994, in conscious gerbils |
| Q28191762 | Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models |
| Q73910670 | Apparent antinociceptive and anti-inflammatory effects of GYKI 52466 |
| Q72033041 | Attenuation of NMDA-induced spinal hypersensitivity by adrenal medullary transplants |
| Q41240200 | Biochemical aspects of chronic pain and its relationship to treatment |
| Q45082670 | Blockade of the antinociceptive activity of centrally administered ketorolac by nor-binaltorphimine |
| Q38365855 | Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior |
| Q46044403 | COX-1-dependent prostaglandin D2 in microglia contributes to neuropathic pain via DP2 receptor in spinal neurons |
| Q24653404 | COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia |
| Q37073724 | COX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice |
| Q24337300 | Calcium influx and protein kinase C alpha activation mediate arachidonic acid mobilization by the human NK-2 receptor expressed in Chinese hamster ovary cells |
| Q40721486 | Central analgesic activity of nonsteroidal antiinflammatory drugs in animal and human pain models |
| Q53961214 | Central and peripheral actions of the NSAID ketoprofen on spinal cord nociceptive reflexes. |
| Q34469703 | Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin |
| Q44594631 | Central components of the analgesic/antihyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia |
| Q48345104 | Central effect of ketorolac involving NMDA receptors activity. |
| Q82028755 | Chapter 14 Descending excitatory systems |
| Q28365869 | Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice |
| Q42701449 | Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice |
| Q41718971 | Characterization of spinal amino acid release and touch-evoked allodynia produced by spinal glycine or GABA(A) receptor antagonist |
| Q43548479 | Characterization of the glutamatergic system for induction and maintenance of allodynia. |
| Q43505670 | Chronic intrathecal cannulation enhances nociceptive responses in rats |
| Q30360728 | Clinical Pharmacology and Cardiovascular Safety of Naproxen |
| Q40328713 | Co-induction of cyclooxygenase-2 [correction of cyclooxyenase-2] and early growth response gene (Egr-1) in spinal cord in a clinical model of persistent inflammation and hyperalgesia |
| Q42757575 | Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance |
| Q46669656 | Constitutive cyclo-oxygenase-2 does not contribute to the development of human visceral pain hypersensitivity. |
| Q37699479 | Constitutive cyclooxygenase-2 is involved in central nociceptive processes in humans |
| Q51507983 | Controlled release and dura mater permeability of lidocaine and ibuprofen from injectable poloxamer-based gels. |
| Q51524955 | Controlled release gel of ibuprofen and lidocaine in epidural use--analgesia and systemic absorption in pigs. |
| Q34139435 | Current experience with 5-HT3 receptor antagonists in fibromyalgia |
| Q44589927 | Cyclo-oxygenase-2 contributes to central sensitization in rats with peripheral inflammation |
| Q43621348 | Cyclooxygenase-1 vs. cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes. |
| Q41646498 | Cyclooxygenases and the central nervous system |
| Q40473376 | Cytokine-to-brain communication: A review & analysis of alternative mechanisms |
| Q44264983 | Differential efficacy of intrathecal NMDA receptor antagonists on inflammatory mechanical and thermal hyperalgesia in rats |
| Q73784501 | Differential potentiative effects of glutamate receptor antagonists in the production of antinociception induced by opioids administered intrathecally in the mouse |
| Q33679568 | Distinct neurochemical features of acute and persistent pain |
| Q33944600 | Distribution and function of prostanoid receptors: studies from knockout mice |
| Q36969685 | Distribution of Spinal Sensitization Evoked by Inflammatory Pain Using Local Spinal Cord Glucose Utilization Combined with (3) H-Phorbol 12,13-Dibutyrate Binding in Rats |
| Q34346670 | Dose-related effects of ibuprofen on pain-related potentials |
| Q44004715 | Downregulation of P2X3 receptor-dependent sensory functions in A/J inbred mouse strain |
| Q40604188 | Drug chirality: on the mechanism of R-aryl propionic acid class NSAIDs. Epimerization in humans and the clinical implications for the use of racemates |
| Q35062919 | Drug therapy in dental practice: nonopioid and opioid analgesics |
| Q35152153 | Dynorphin and the hypothalamo-pituitary-adrenal axis during fetal development |
| Q45129816 | Early painful diabetic neuropathy is associated with differential changes in the expression and function of vanilloid receptor 1. |
| Q42276965 | Effect of NMDA receptor antagonists on prostaglandin E2-induced hyperalgesia in conscious mice |
| Q36516256 | Effect of Premedication with Indomethacin and Ibuprofen on Postoperative Endodontic Pain: A Clinical Trial. |
| Q53441224 | Effect of a single dose of meloxicam prior to band or knife castration in 1-wk-old beef calves: I. Acute pain. |
| Q51557669 | Effect of pre- vs postoperative tonsillar infiltration with local anesthetics on postoperative pain after tonsillectomy. |
| Q42453123 | Effect of repeated cold stress on capsaicin-evoked release of glutamate from rat spinal dorsal horn slices |
| Q42023129 | Effect of the NMDA-antagonist, MK 801, on benzodiazepine-opioid interactions at the spinal and supraspinal level in rats |
| Q74238294 | Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on prostaglandin E(2) synthesis in rat microglial cells |
| Q34074682 | Effects of intrathecal ketorolac on human experimental pain |
| Q39467172 | Effects of metamizol on nociceptive responses to stimulation of the ureter and on ureter motility in anaesthetised rats |
| Q39419211 | Efficacy and safety of repeated postoperative administration of intramuscular diclofenac sodium in the treatment of post-cesarean section pain: a double-blind study |
| Q34037670 | Electroacupuncture mediates extracellular signal-regulated kinase 1/2 pathways in the spinal cord of rats with inflammatory pain |
| Q46083475 | Emerging drugs for neuropathic pain |
| Q64889058 | Endoperoxide 4 receptors play a role in evoking the exercise pressor reflex in rats with simulated peripheral artery disease. |
| Q42066400 | Evaluation of Postoperative Anti-nociceptive Efficacy of Intrathecal Dexketoprofen in Rats |
| Q51577891 | Evaluation of periapical injection of Ketorolac for management of endodontic pain. |
| Q42049298 | Evaluation of the combination of flurbiprofen and tramadol for management of endodontic pain |
| Q60061940 | Expression and regulation of prostaglandin E receptor subtype mRNAs in rat sensory ganglia and spinal cord in response to peripheral inflammation |
| Q34998028 | Function of prostanoid receptors: studies on knockout mice |
| Q33784210 | Functional neurokinin and NMDA receptor activity in an animal naturally lacking substance P: the naked mole-rat |
| Q57990320 | GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain |
| Q57318961 | Guidelines for Recognition, Assessment and Treatment of Pain |
| Q74147278 | Hyperalgesia induced by peripheral inflammation is mediated by protein kinase C betaII isozyme in the rat spinal cord |
| Q38326421 | Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites |
| Q42706612 | In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs |
| Q35028598 | In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin |
| Q36007602 | Inflammatory mediators potentiate high affinity GABA(A) currents in rat dorsal root ganglion neurons |
| Q43177787 | Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2. |
| Q46973494 | Inhibition of spinal protein kinase C blocks substance P-mediated hyperalgesia |
| Q37740081 | Interaction between maropitant and carprofen on sparing of the minimum alveolar concentration for blunting adrenergic response (MAC-BAR) of sevoflurane in dogs |
| Q33939152 | Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity |
| Q73676136 | Intrathecal N-methyl-D-aspartate (NMDA) induces paradoxical analgesia in the tail-flick test in rats |
| Q44432820 | Intrathecal adenosine A1 receptor agonist attenuates hyperalgesia without inhibiting spinal glutamate release in the rat |
| Q50535515 | Intrathecal administration of prostaglandin E2 causes sensitization of the primary afferent neuron via the spinal release of glutamate. |
| Q71652889 | Intrathecal excitatory amino acid (EAA) agonists increase tail flick latencies (TFLs) of spinal rats |
| Q34062378 | Intrathecal ketorolac does not improve acute or chronic pain after hip arthroplasty: a randomized controlled trial |
| Q71612212 | Intrathecal ketorolac tromethamine produces analgesia after chronic constriction injury of sciatic nerve in rat |
| Q41613425 | Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids |
| Q34011229 | Is fibromyalgia a distinct clinical syndrome? |
| Q39455901 | Ketorolac for postoperative pain management in children |
| Q46920951 | Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat. |
| Q44346622 | Kynurenic acid enhances electroacupuncture analgesia in normal and carrageenan-injected rats |
| Q77194690 | Localization of cyclooxygenase-2 and prostaglandin E2 receptor EP3 in the rat lumbar spinal cord |
| Q53704943 | Lumbar epidural morphine infusions for children undergoing cardiac surgery. |
| Q34040447 | Management of Inflammatory Pain with Selective COX-2 Inhibitors: Promises and Facts |
| Q41078770 | Mechanisms of chronic pain |
| Q78207290 | Mediation and modulation by eicosanoids of responses of spinal dorsal horn neurons to glutamate and substance P receptor agonists: results with indomethacin in the rat in vivo |
| Q36374283 | Medical treatment of osteoarthritis in the horse - a review |
| Q41815926 | Milnacipran inhibits glutamatergic N-methyl-D-aspartate receptor activity in spinal dorsal horn neurons. |
| Q33740802 | Modern concepts of paediatric analgesia |
| Q28216291 | Molecular mechanisms of nociception |
| Q78108265 | NMDA-induced spinal hypersensitivity is reduced by naturally derived peptide analog [Ser1]histogranin |
| Q46378238 | NMDA-receptor regulation of substance P release from primary afferent nociceptors |
| Q33664210 | NSAIDs and Acute Pancreatitis: A Systematic Review |
| Q37929796 | Neoteric pharmacotherapeutic targets in fibromyalgia |
| Q35030898 | Neurologic deficits and arachnoiditis following neuroaxial anesthesia |
| Q44350969 | Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems |
| Q30834976 | Nitric oxide synthase and glutamate receptor immunoreactivity in the rat spinal trigeminal neurons expressing Fos protein after formalin injection |
| Q41959104 | No preemptive analgesic effect of preoperative ketorolac administration following total abdominal hysterectomy: A randomized study |
| Q44762691 | Nonopioid actions of intrathecal dynorphin evoke spinal excitatory amino acid and prostaglandin E2 release mediated by cyclooxygenase-1 and -2. |
| Q41121621 | Nonopioid and opioid analgesic pharmacotherapy of cancer pain. |
| Q72751829 | Nonsteroidal anti-inflammatory drugs |
| Q39478947 | Nonsteroidal anti-inflammatory drugs in perisurgical pain management. Mechanisms of action and rationale for optimum use. |
| Q46647198 | Opioid-induced analgesia and hyperalgesia |
| Q44807834 | Opioid-induced hyperalgesia. Pathophysiology and clinical relevance |
| Q38157117 | Osteoarthritis of the hand II: chemistry, pharmacokinetics and pharmacodynamics of naproxen, and clinical outcome studies |
| Q33822229 | Pain facilitatory circuits in the mammalian central nervous system: their behavioral significance and role in morphine analgesic tolerance |
| Q36148700 | Pain management for dentists: the role of ibuprofen. |
| Q33918219 | Pain management: Part 1: Managing acute and postoperative dental pain |
| Q43070929 | Pain treatment in multimorbid patients, the older population and other high-risk groups. The clinical challenge of reducing toxicity |
| Q32052639 | Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches |
| Q38050994 | Paracetamol in the environment and its degradation by microorganisms |
| Q32065380 | Pathophysiological basis of acute inflammatory hyperaemia in the rat knee: roles of cyclo-oxygenase-1 and -2. |
| Q39423228 | Pathophysiology of joint pain |
| Q35028007 | Peripheral and/or central effects of racemic-, S(+)- and R(-)-flurbiprofen on inflammatory nociceptive processes: a c-Fos protein study in the rat spinal cord |
| Q37314270 | Peripheral mechanisms of pain and analgesia |
| Q34282592 | Pharmacologic management of pain: the surgeon's responsibility. |
| Q34185102 | Pharmacologic treatment of neuropathic pain |
| Q36652103 | Pharmacological analysis of cyclooxygenase-1 in inflammation |
| Q37915538 | Pharmacological treatment of opioid-induced hyperalgesia: a review of the evidence |
| Q52167461 | Phenacetin, acetaminophen and dipyrone: analgesic and rewarding effects. |
| Q43241364 | Postoperative pain control after cesarean section: can diclofenac sodium be used instead of meperidine? |
| Q34800386 | Potential mechanisms of neuropathic pain in diabetes |
| Q39476283 | Pre-emptive Analgesia: A Systematic Review of Clinical Studies |
| Q71576556 | Pre-emptive analgesia: what does it mean to the clinical anaesthetist? |
| Q38668522 | Preclinical Assessment of Inflammatory Pain |
| Q39456105 | Principles of analgesic drug therapy. |
| Q44341481 | Prior ibuprofen exposure does not augment opioid drug potency or modify opioid requirements for pain inhibition in total hip surgery |
| Q46476096 | Production of prostaglandins D2 and E2 by mouse fibroblasts and astrocytes in culture caused by Trypanosoma brucei brucei products and endotoxin |
| Q34199035 | Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord |
| Q48556921 | Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. |
| Q24801007 | Psychological stress and fibromyalgia: a review of the evidence suggesting a neuroendocrine link |
| Q46242157 | Randomized, double-blind, placebo-controlled, dose-escalation study: Investigation of the safety, pharmacokinetics, and antihyperalgesic activity of l-4-chlorokynurenine in healthy volunteers |
| Q51371003 | Relationship between nociceptor activity, peripheral edema, spinal microglial activation and long-term hyperalgesia induced by formalin. |
| Q48771497 | Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients |
| Q28191840 | Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol |
| Q86950831 | Role of neurokinin type 1 receptor in nociception at the periphery and the spinal level in the rat |
| Q37245429 | Secondary hyperalgesia in the rat first degree burn model is independent of spinal cyclooxygenase and nitric oxide synthase |
| Q41194915 | Selective activation of microglia facilitates synaptic strength |
| Q72061477 | Selective antinociceptive effect of excitatory amino acid antagonists in intact and acute spinal rats |
| Q24648979 | Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion |
| Q74122150 | Sensory neurons are PARtial to pain |
| Q43989935 | Site and mechanism of action of dynorphin A-(1-13) and N-methyl-D-aspartate on ACTH release in fetal sheep |
| Q36999946 | Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways |
| Q28264127 | Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors |
| Q71655625 | Spinal Mediators of Hyperalgesia |
| Q43263513 | Spinal amino acid release and repeated withdrawal in spinal morphine tolerant rats |
| Q73863040 | Spinal cyclooxygenase-2 is involved in development of allodynia after nerve injury in rats |
| Q30856262 | Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype |
| Q34989480 | Spinal phosphinositide 3-kinase-Akt-mammalian target of rapamycin signaling cascades in inflammation-induced hyperalgesia |
| Q35048741 | Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2 |
| Q74529110 | Substance P receptor (neurokinin-1)-expressing neurons in lamina I of the spinal cord encode for the intensity of noxious stimulation: a c-Fos study in rat |
| Q40934029 | Subunit-selective modulation of GABAA receptors by the non-steroidal anti-inflammatory agent, mefenamic acid |
| Q36495153 | Synergistic depression of NMDA receptor-mediated transmission by ketamine, ketoprofen and L-NAME combinations in neonatal rat spinal cords in vitro |
| Q44589938 | Systemic, but not intrathecal ketorolac is antinociceptive to uterine cervical distension in rats |
| Q34119549 | Tachykinin receptor modulators: novel therapeutics for rheumatoid arthritis |
| Q33567180 | The Antinociceptive Effect of Light-Emitting Diode Irradiation on Incised Wounds Is Correlated with Changes in Cyclooxygenase 2 Activity, Prostaglandin E2, and Proinflammatory Cytokines |
| Q47380004 | The Effect of Spinal and Systemic Administration of Indomethacin on Zymosan-Induced Edema, Mechanical Hyperalgesia, and Thermal Hyperalgesia |
| Q40394262 | The Spinal Actions of Nonsteroidal Anti-Inflammatory Drugs and the Dissociation between their Anti-Inflammatory and Analgesic Effects |
| Q43697187 | The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. |
| Q77408879 | The clinical effect of ketoprofen after arthroscopic subacromial decompression: a randomized double-blind prospective study |
| Q44876234 | The clinical, cerebrospinal fluid, and histopathologic effects of epidural ketorolac in dogs |
| Q42705743 | The dose-related effects of paracetamol on hyperalgesia and nociception in the rat. |
| Q42369976 | The effect of morphine on formalin-evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats |
| Q47836232 | The effects of S- and R-flurbiprofen on the inflammation-evoked intraspinal release of immunoreactive substance P--a study with antibody microprobes |
| Q38816556 | The efficacy of non-narcotic analgesics on post-operative endodontic pain: A systematic review and meta-analysis: The efficacy of non-steroidal anti-inflammatory drugs and/or paracetamol on post-operative endodontic pain. |
| Q48284194 | The induction of pain: an integrative review |
| Q41217565 | The mechanisms of action of NSAIDs in analgesia |
| Q34347558 | The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings |
| Q33639054 | The neurobiology of pain |
| Q73980279 | The neurokinin-1 receptor antagonist RP 67580 reduces the sensitization of primary afferents by substance P in the rat |
| Q71524014 | The non-peptide NK1 receptor antagonist SR140333 produces long-lasting inhibition of neurogenic inflammation, but does not influence acute chemo- or thermonociception in rats |
| Q36411163 | The pharmacotherapy of chronic pain: a review |
| Q73343907 | The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia |
| Q34746456 | The promise of substance P inhibitors in fibromyalgia |
| Q35542240 | The role of COX-2 inhibitors in pain modulation |
| Q40622661 | The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats |
| Q31374928 | The role of nitric oxide and prostaglandin E2 on the hyperalgesia induced by excitatory amino acids in rats |
| Q78182313 | The role of systemic, spinal and supraspinal L-arginine-nitric oxide-cGMP pathway in thermal hyperalgesia caused by intrathecal injection of glutamate in mice |
| Q33679499 | The spinal biology in humans and animals of pain states generated by persistent small afferent input |
| Q33542921 | The use of analgesics in the management of pain in rheumatic diseases |
| Q71940261 | Thermal hyperalgesia in rat evoked by intrathecal substance P at multiple stimulus intensities reflects an increase in the gain of nociceptive processing |
| Q42554771 | Tonic versus phasic pain: dose-related effects of ketoprofen |
| Q44454428 | Unaltered pain-related behavior in mice lacking NMDA receptor GluRepsilon 1 subunit |
| Q33922000 | Use and abuse of over-the-counter analgesic agents |
| Q39471588 | Use of nonsteroidal anti-inflammatory drugs in cancer |
| Q80975604 | [Combined analgesics for postoperative pain therapy. Review of effectivity and side-effects] |
| Q81093171 | [Non-steroidal anti-inflammatory drugs (NSAIDs): Antirheumatic, anti-pyretic or analgesic drugs?] |
| Q77401346 | [Propacetamol: from basic action to clinical utilization] |